Literature DB >> 23899470

Advanced oxidation protein products enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia.

Q T Huang1, S S Wang, M Zhang, L P Huang, J W Tian, Y H Yu, Z J Wang, M Zhong.   

Abstract

Accumulation of advanced oxidation protein products (AOPPs) is prevalent in obesity, advanced maternal age, diabetes mellitus, and polycystic ovary syndrome. Alterations in the regulation and signaling of angiogenic pathways have been recognized as a link between these conditions and pre-eclampsia. To investigate the possible impact of AOPPs on soluble Fms-like tyrosine kinase 1 (sFlt-1) expression in trophoblasts. A trophoblast cell line (HRT-8/SVneo) was treated with various concentrations of AOPPs. The mRNA expression of sFlt-1, vascular endothelial growth factor (VEGF), and placental growth factor (PlGF) in trophoblasts were measured with the use of real-time polymerase chain reaction; and the secretion of sFlt-1, VEGF, and PlGF protein from trophoblasts were detected with the use of ELISA. Exposure of HRT-8/SVneo cells to AOPPs induced overexpression of sFlt-1 at mRNA and protein levels in a dose dependent manner. These effects could be inhibited by apocynin, an inhibitors of NADPH oxidase. Our data identified AOPPs as a class of important mediator in the regulation and signaling of angiogenic pathways of trophoblasts. Accumulation of AOPPs might contributes to the pathogenesis of preeclampsia by promoting sFlt-1 production in trophoblasts.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Advanced oxidation protein products; Soluble Fms-like tyrosine kinase 1; Trophoblast

Mesh:

Substances:

Year:  2013        PMID: 23899470     DOI: 10.1016/j.placenta.2013.06.308

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  7 in total

1.  Increased Oxidatively Modified Forms of Albumin in Association with Decreased Total Antioxidant Activity in Different Types of Hypertensive Disorders of Pregnancy.

Authors:  Jyothi M P D'souza; Sindhu Harish; Vinitha Ramanath Pai; Chitra Shriyan
Journal:  Indian J Clin Biochem       Date:  2016-06-07

Review 2.  Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.

Authors:  Manuel Luque-Ramírez; Héctor F Escobar-Morreale
Journal:  Curr Hypertens Rep       Date:  2014-12       Impact factor: 5.369

3.  Sulforaphane Bioavailability and Effects on Blood Pressure in Women with Pregnancy Hypertension.

Authors:  A G Langston-Cox; D Anderson; D J Creek; K R Palmer; S A Marshall; E M Wallace
Journal:  Reprod Sci       Date:  2021-01-06       Impact factor: 3.060

4.  Effect of edaravone on pregnant mice and their developing fetuses subjected to placental ischemia.

Authors:  Marwa Atallah; Toru Yamashita; Koji Abe
Journal:  Reprod Biol Endocrinol       Date:  2021-02-06       Impact factor: 5.211

5.  Serum biomarkers combined with uterine artery Doppler in prediction of preeclampsia.

Authors:  Lijie Li; Yanmei Zheng; Ying Zhu; Jianchun Li
Journal:  Exp Ther Med       Date:  2016-08-29       Impact factor: 2.447

Review 6.  Oxidative Stress in Preeclampsia and Placental Diseases.

Authors:  Rajaa Aouache; Louise Biquard; Daniel Vaiman; Francisco Miralles
Journal:  Int J Mol Sci       Date:  2018-05-17       Impact factor: 5.923

7.  Advanced Oxidation Protein Products Induce G1/G0-Phase Arrest in Ovarian Granulosa Cells via the ROS-JNK/p38 MAPK-p21 Pathway in Premature Ovarian Insufficiency.

Authors:  Xing-Yu Zhou; Jun Zhang; Ying Li; Ying-Xue Chen; Xiao-Min Wu; Xin Li; Xiao-Fei Zhang; Lin-Zi Ma; Yi-Zhen Yang; Ke-Ming Zheng; Yu-Dong Liu; Zhe Wang; Shi-Ling Chen
Journal:  Oxid Med Cell Longev       Date:  2021-07-27       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.